Structural elucidation of the cis-prenyltransferase NgBR/DHDDS complex reveals insights in regulation of protein glycosylation
- Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20794-20802. doi: 10.1073/pnas.2008381117.
- 1. Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520.
- 2. Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
- 3. Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106, Warsaw, Poland.
- 4. Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520; [email protected] [email protected].
- 5. Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520; [email protected] [email protected].
Cis-prenyltransferase (cis-PTase) catalyzes the rate-limiting step in the synthesis of glycosyl carrier lipids required for protein glycosylation in the lumen of endoplasmic reticulum. Here, we report the crystal structure of the human NgBR/DHDDS complex, which represents an atomic resolution structure for any heterodimeric cis-PTase. The crystal structure sheds light on how NgBR stabilizes DHDDS through dimerization, participates in the enzyme's active site through its C-terminal -RXG- motif, and how Phospholipids markedly stimulate cis-PTase activity. Comparison of NgBR/DHDDS with homodimeric cis-PTase structures leads to a model where the elongating isoprene chain extends beyond the enzyme's active site tunnel, and an insert within the α3 helix helps to stabilize this energetically unfavorable state to enable long-chain synthesis to occur. These data provide unique insights into how heterodimeric cis-PTases have evolved from their ancestral, homodimeric forms to fulfill their function in long-chain polyprenol synthesis.